March 3, 2021By DDN StaffUncovering the origins of malignant rhabdoid tumorsResearchers discover how malignant rhabdoid tumors begin, and identify potential treatments
March 2, 2021By Jeffrey BouleyCancer and clinical trials in the spotlightMarch is still the month where we put extra attention on cancer, but the landscape is different in a pandemic
March 2, 2021By Jeffrey BouleyFocus Feature on CancerWe explore advances in women’s cancers in addition to other recent oncology news
March 1, 2021By Mel J. YeatesFDA approves PepaxtoOncopeptides’ Pepaxto has been approved for patients with triple-class refractory multiple myeloma
Clinical ResearchFebruary 25, 2021By DDN StaffGENUINE progressTG Therapeutics' GENUINE trial shows that ublituximab plus ibrutinib improves survival in patients with chronic lymphocytic leukemia
February 25, 2021By DDN StaffAn alliance for drug developmentUCLA researchers to select candidates for development with Xencor’s modular XmAb platforms
February 24, 2021By Mel J. YeatesBringing down the cost of cancer?NuView’s theranostics approach could make cancer diagnosis and treatment more affordable
February 24, 2021By Kelsey KaustinenA different kind of TROLLAPIS and Moffitt pair up to assess TROLL lncRNAs as predictive biomarkers in cancer
February 19, 2021By Mel J. YeatesIn pursuit of pancreatic cancerStudy finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
DiscoveryFebruary 11, 2021By DDN StaffaTyr begins new tRNA programsaTyr Pharma initiates two new tRNA synthetase discovery programs